Analysed AGENUS INC (AGEN:NASDAQ) News Sources
Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
11-05-2026
yahoo.com
Agenus Announces Publication of Phase 1b Botensilimab and Balstilimab Data in Post-Immunotherapy Hepatocellular Carcinoma in Liver Cancer
15-05-2026
yahoo.com
Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
21-05-2026
yahoo.com
Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
21-05-2026
yahoo.com
What is the current price of AGENUS INC (AGEN:NASDAQ)?
The current price of AGENUS INC (AGEN:NASDAQ) is $3.49.
AGENUS INC (AGEN:NASDAQ) absolute price change since previous trading day?
The absolute price change of AGENUS INC (AGEN:NASDAQ) since the previous trading day is $0.09.
AGENUS INC (AGEN:NASDAQ) percentage price change since previous trading day?
The percentage price change of AGENUS INC (AGEN:NASDAQ) since the previous trading day is 2.6471%.
What is the most recent average sentiment score for AGENUS INC (AGEN:NASDAQ)?
The most recent average sentiment score for AGENUS INC (AGEN:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for AGENUS INC (AGEN:NASDAQ)?
The most recent sentiment for AGENUS INC (AGEN:NASDAQ) is .
SEC-8K** Filing Available For AGENUS INC (AGEN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.